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INTRODUCTION
Migraine is a highly prevalent illness, and women of repro-
ductive ages are more affected by it than men or women in
other age groups (1). Many researchers have supported the
view that behavioral interventions such as biofeedback and
relaxation, either alone or in combination, can be effective
for the treatment of headache (2-7). Especially, thermal bio-
feedback with or without combined autogenic training is
known to be effective for the treatment of migraine headache
(5, 8). In addition, some studies showed that the effect of the
behavioral treatment is durable (9, 10). There have been no
controlled studies about the efficacy of biofeedback and relax-
ation training for patients with migraine in Korea, and few
studies have been conducted to investigate the direct associ-
ation between mood states, including anxiety or depression,
and headache activity. The mechanism underlying the effi-
cacy of biofeedback treatment and the role of psychological
factors in migraine treatment are still unclear, though vari-
ous mood states, including anxiety and depression, and some
cognitive factors are known to be related to pain regulation
(11-13). Psychological conditions including anxiety and de-
pression have been reported to have a strong association with
migraine (12-14). 
Thus, in this study, we examined the hypothesis that bio-
feedback-assisted autogenic training is effective for the treat-
ment of Korean female patients with migraine and that the
improvement of psychological factors, such as anxiety and
depression, is associated with the reduction of headache activ-
ity in migraine patients who are given biofeedback treatment. 
MATERIALS AND METHODS
Subjects
Thirty-two patients, who had migraine headache with or
without aura, as defined by the International Headache Soci-
ety criteria (15), participated in this study, from March 2003
until December 2006. The patients were female subjects aged
20 to 40 yr who had a body mass index (BMI) ranging from
18 to 27.5. They were among the migraineurs who visited
the Samsung Medical Center. The patients were randomly
allocated to one of two patient groups, consisting of a treat-
ment group receiving biofeedback-assistant relaxation treat-
ment (n=17) and a monitoring group in which the headache
activities and biofeedback parameters of the patients were sim-
ply measured (n=15). These two groups did not show any
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Effect of Biofeedback-assisted Autogenic Training on Headache 
Activity and Mood States in Korean Female Migraine Patients
Biofeedback with or without combined autogenic training is known to be effective
for the treatment of migraine. This study aimed to examine the effect of biofeedback
treatment on headache activity, anxiety, and depression in Korean female patients
with migraine headache. Patients were randomized into the treatment group (n=17)
and monitoring group (n=15). Mood states including anxiety and depression, and
psychophysiological variables such as mean skin temperature of the patients were
compared with those of the normal controls (n=21). We found greater treatment
response rate (defined as ≥50% reduction in headache index) in patients with bio-
feedback-assisted autogenic training than in monitoring group. The scores on the
anxiety and depression scales in the patients receiving biofeedback-assisted auto-
genic training decreased after the biofeedback treatment. Moreover, the decrease
in their anxiety levels was significantly related to the treatment outcome. This result
suggests that the biofeedback-assisted autogenic training is effective for the treat-
ment of migraine and its therapeutic effect is closely related to the improvement of
the anxiety level. 
Key Words : Migraine; Biofeedback; Autogenic Training; Anxiety; Depression
Received : 5 June 2008
Accepted : 10 October 2008Biofeedback Treatment and Migraine 937
significant difference in the duration of headache, headache
index, duration of medication use, or other headache-related
variables at the baseline (Table 1). Twenty-one normal female
volunteers were recruited by advertisement and were matched
with the migraine patients by age (treatment group: 31.12
±5.49 yr, monitoring group: 31.87±4.70 yr, normal con-
trol group: 29.38±4.64 yr), and mood states and mean skin
temperature of the patients before the biofeedback treatment
were compared with those of the normal control subjects.
Each subject underwent a comprehensive medical and psy-
chiatric assessment including careful history taking, physi-
cal examination, neurological examination, mental status
examination, and electrocardiography. Those patients who
seemed to suffer from secondary headache due to medical or
psychiatric illnesses were not included in the study. They did
not take regular medications for migraine headache, and only
pro re nata (p.r.n.) medication such as sumatriptan was per-
mitted during the study. This study was approved by the
Institutional Review Board of Samsung Medical Center, and
all of the subjects gave their written informed consent.
Procedure & Treatment
The patients in the treatment group received 8 sessions of
biofeedback-assisted autogenic training (two sessions per
week) during a period of 4 weeks, while those in the moni-
toring group received no active intervention except for sim-
ple biofeedback measurements (1st, 4th, and 8th session) dur-
ing the treatment-waiting period. Biofeedback treatment
was administered with the patient sitting on a comfortable
arm-chair in a quiet room in the psychiatric outpatient clin-
ic of Samsung Medical Center. A Procomp+system and Bio-
graph version 2.1 program (Thought Technology Ltd., Que-
bec, Canada) were used for the biofeedback treatment and
measurements. 
Each biofeedback-assisted autogenic training session last-
ed about 45-50 min. The autogenic training procedures con-
sisted of 6 standard exercises combining both relaxation and
auto-suggestion (limb heaviness exercise, limb warmth exer-
cise, cardiac exercise, respiration exercise, solar plexus warmth
exercise, and ‘‘forehead cooling’’ exercise) (16). During the
1st session, after the baseline profiles were obtained, educa-
tion in relaxation techniques was given to the patients in the
treatment group. During the 2nd to 8th sessions, thermal
biofeedback combined with autogenic training was provid-
ed. For the first 15-20 min, after collecting the headache diary
data, the patients were rated on psychological variables and
headache severity. The patients were trained to increase their
skin temperature by an experienced biofeedback therapist
for about 15 min according to the procedures described in a
treatment manual. During the last 15 min, they were instruct-
ed to continue the relaxation exercise by themselves, while
listening to a prerecorded tape. They were also asked to per-
form autogenic training as homework between the sessions.
Measures of pain and psychological variables
Headache indices were obtained using a daily headache diary
over 7 consecutive days. Success was defined as a 50% reduc-
tion in the score. The headache severity was rated on a 6-point
rating scale with 0 representing ‘‘no pain’’ and 5 representing
‘‘pain as severe as it can be’’. The headache severity was record-
ed every hour except during sleep. The average frequency,
duration, and intensity of pain during the 7 consecutive days
were compiled as headache indexes. Headache indexes at base-
line, after 2 weeks, and after 4 weeks of biofeedback treatment
were used to compare the two groups.
Secondary outcomes were evaluated using the MPQ (17)
and the Clinical Global Impression severity scale (CGI-S) ad-
ministered by the therapist. The baseline headache variables
were recorded for the previous 1 week before the treatment
and the follow-up headache variables as the mean of the symp-
toms during the previous week. Due to the possibility of there
being a change in the perception of pain according to the
menstrual cycle (18), the menstruation phase was determined
by asking the subjects the onset of their last menstruation.
Before the biofeedback treatment, there were no differences
in the headache indices and mood states between the treat-
ment group and monitoring group according to the men-
struation phase. 
The psychological assessments for anxiety and depressive
symptoms were performed using the Hamilton Rating Scales
for Anxiety (HAM-A) (19) and Depression (HAM-D) (20),
and the Spielberger State Anxiety Inventory (STAI-S) (21). The
CGI-S, HAM-A, and HAM-D were performed by a well-tra-
Data are given as n (%) or mean±S.D.
BMI, body mass index; MPQ-S, the McGill Pain Questionnaire-Senso-
ry; MPQ-A, the McGill Pain Questionnaire-affective; CGI-S, the Clinical
Global Impression for Severity.
Biofeedback-
assisted
autogenic
training
group (n=17)
Parameters
Monitoring-
only 
group 
(n=15)
P
value
Age (yr) 31.12±5.49 31.87±4.70 0.68
BMI 20.40±1.89 20.64±2.41 0.76
Familial loading 9 (52.9%) 8 (53.3%) 0.98
With aura 4 (21.1%) 3 (15.8%) 0.68
Follicular menstrual phase  12 (70.6%) 11 (73.3%) 0.86
on first evaluation
Duration of headache (yr) 9.0±5.86 8.60±5.70 0.77
Duration of medication use (yr) 9.06±4.74 6.05±6.39 0.15
Headache index 0.60±0.69 0.71±0.41 0.09
MPQ-S 11.06±5.18 9.85±4.0 0.72
MPQ-A 5.88±2.73 4.30±1.76 0.12
CGI-S 4.88±0.93 4.40±0.74 0.12
Resting skin temperature (°C) 32.47±3.04 33.18±2.08 0.46
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ined psychiatrist who was blind to the patients’ clinical states.
Data analyses
To compare the baseline values, chi-square test, Fisher’s exact
test, and analysis of variance (ANOVA) were used. Treatment
outcome analysis in terms of headache index was preformed
using chi-square test. Repeated measures ANOVA was per-
formed to analysis mean changes of skin temperature, psy-
chological variables, and secondary pain outcomes. Student’s
t-test with Bonferroni’s correction was performed for post hoc
analysis. Univariate and multivariate logistic regression anal-
yses were used to whether the baseline or changes of depres-
sion and anxiety level could predict the treatment outcome.
All of the analyses were performed using the SPSS 13.0 sta-
tistical software.
RESULTS
The Fisher’s exact test revealed a significant difference in
the response rate in terms of headache index between the two
groups ( 2=4.979, df=1, P=0.029). Ten of the 17 patients
(58.9%) in the treatment group showed a significant impro-
vement in their headache index corresponding to a 50% or
greater reduction in their headache activity, whereas only 3
of the 15 subjects (20%) in the monitoring group achieved a
significant improvement (Fig. 1). Repeated measures ANOVA
indicated that there were significant interactions between time
and group in the MPQ-S (F=6.994, P=0.014), MPQ-A (F=
9.978, P=0.006), and CGI-S (F=16.160, P=0.001). Mean
resting skin temperatures did not show any differences between
the treatment and monitoring group, nor pre- and post-treat-
ment (all Pvalues >0.1).
The results of the comparisons of the psychological states
of the three groups are shown in Table 2. The anxiety and
depression levels in the migraine patients were significantly
higher than those in the normal control subjects at the base-
line (all P values <0.001). There were no group differences
between the biofeedback-assisted autogenic training group
Fig. 1. Greater treatment response rate (defined as ≥50% reduc-
tion in headache index) was observed in patients with biofeed-
back-assisted autogenic training than in monitoring-only group
(58.9% vs. 20%, 
2=4.979, d=1, P=0.029).
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Data are given as mean±S.D.
*Significant by one-way analysis of variance (ANOVA). Post hoc analy-
sis revealed that there were no significant differences in the mood states
between the treatment and monitoring groups, whereas there was a
significant differences between the patient group and normal controls
(P<0.01, by Bonferroni’s correction).
HAM-A, the Hamilton Rating Scale for Anxiety; STAI-S, the Spielberger
State Anxiety Inventory; HAM-D, the Hamilton Rating Scale for Depres-
sion.
Biofeedback-
assisted
autogenic
training
group (n=17)
Monitoring-
only 
group 
(n=15)
Normal 
controls
(n=21)
P
value
HAM-A 10.41±5.67 9.47±5.13 4.57±2.91 0.001*
STAI-S 44.12±10.85 42.33±13.10 33.48±5.54 0.001*
HAM-D 12.24±4.05 12.80±5.90 3.43±2.29 0.001*
Table 2. Mood states of migraine patients and normal control
subjects at baseline
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Fig. 2. Mood states by treatment group (Biofeedback-assisted autogenic training group vs. monitoring-only group). There were significant
interactions between the two groups in changes of the HAM-A (F=10.560, P=0.003), HAM-D (F=8.161, P=0.013), and STAI-S (F=12.320,
P=0.002). Post hoc analyses revealed that there were significant differences at the endpoint between the two groups in all the mood states
(all P values <0.1).
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and the monitoring group. 
Fig. 2 shows the results of the repeated-measures ANOVA
in the psychological variables. Significant interactions between
time and group were found for the HAM-A (F=10.560, P=
0.003), HAM-D (F=8.161, P=0.013), and STAI-S (F=12.320,
P=0.002). Post hoc analysis revealed that there were signifi-
cant between-group differences at the endpoint (P=0.002,
0.032, 0.001, respectively). 
Age, BMI, the baseline HAM-D, HAM-A, and STAI-S
were not associated with treatment response in terms of head-
ache index (all Pvalues >0.1) in the biofeedback-assisted train-
ing group. However, the multivariate logistic regression re-
vealed that the greater reduction of the HAM-A score was
associated with the treatment response controlling for age,
BMI, and the baseline HAM-A in the biofeedback-assisted
autogenic training group (OR=1.52, CI=1.01-2.33, P=0.048)
whereas the reduction of the HAM-D score nor that of the
STAI-S were not (P=0.088 and P=0.080, respectively).
DISCUSSION
We found that biofeedback-assisted autogenic training is
effective in management of female migraine patients in Kore-
an population. They also exhibited significant differences in
their mood states measured by the HAM-A, HAM-D, STAI-
S, as compared with the normal healthy women. This find-
ing is consistent with the results of previous studies which
showed that migraine patients had high levels of anxiety and
depression (12, 14, 22). It is also consistent with a previous
report (23) that negative mood states such as anxiety and de-
pression are related to physical complaints and headache. The
anxiety and depression scores in the migraine patients were
reduced after 4 weeks of biofeedback treatment. Furthermore,
the reduction in anxiety level after the biofeedback treatment
was related to the treatment response of the patients. To our
knowledge, there have been no reports about the association
between mood states, including anxiety and depression, and
improvements in headache activity in migraine patients receiv-
ing biofeedback treatment. Our result is also consistent with
the finding of previous studies (24-27) that mood states might
affect the experience of pain through the cognitive process-
ing of nociceptive information, although this hypothesis has
not been directly examined in headache patients. The present
result is in contrast with the previous report (2) that decreased
depression level rather than anxiety was related to the out-
come of biofeedback-assisted training in patients with chron-
ic tension-type headache. Taken together, reduction of anxi-
ety may be related to the biofeedback treatment response of
migraine headache, whereas reduction of depression may be
related to the biofeedback treatment response of chronic ten-
sion-type headache. Further studies will be necessary to con-
firm this difference between migraine and tension type hea-
dache. 
Mean skin temperatures between the pre- and post-treat-
ment changes were not statistically different. Our finding
also suggests that the reduction of anxiety rather than depres-
sion level is more important in the biofeedback treatment of
migraine. This result appears to confirm the previous find-
ings that the treatment mechanism of biofeedback is medi-
ated by an indirect process rather than a direct physiological
change (28, 29). Cognitive factors such as increased self-effi-
cacy belief or coping style can affect the success of biofeed-
back treatment, and anxiety is known to be closely associat-
ed with cognitive factors (11). However, since migraine is
known to be inter-related to anxiety (30), our tentative find-
ing has the limitation that it does not confirm whether an
improvement in anxiety causes a decrease in headache activity.
Further studies are needed to examine the relationship among
mood states, cognitive factors, and headache.
There are several limitations in this study. Firstly, the time
period of the study was short. Migraine is an illness with a
fluctuating course in which the symptoms wax and wane,
and psychophysiological treatment may have a delayed effect.
Secondly, the severity of headache in the recruited patients
was relatively low and the patients in this study may not rep-
resent the general population with migraine headache. Final-
ly, our sample size was relatively small. However, to the best
of our knowledge, this is the first controlled study to exam-
ine the efficacy of biofeedback treatment and the relationship
between mood states and headache activity in Korean migraine
patients. 
In conclusion, biofeedback treatment was found to cause
an improvement of headache and mood states such as anxi-
ety and depression in female migraine patients. In addition,
the reduction of anxiety level was related to the biofeedback
treatment response. These results suggest that biofeedback
treatment can be an effective non-pharmacological treatment
for migraine patients and that the improvement of the anxi-
ety states afforded by biofeedback treatment may play a key
role in reducing headache activity.
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